Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-034545
Filing Date
2024-11-12
Accepted
2024-11-12 16:10:33
Documents
56
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q dyai20240930c_10q.htm   iXBRL 10-Q 1175212
2 EXHIBIT 31.1 ex_721717.htm EX-31.1 9532
3 EXHIBIT 31.2 ex_721718.htm EX-31.2 9404
4 EXHIBIT 32.1 ex_721719.htm EX-32.1 3810
5 EXHIBIT 32.2 ex_721720.htm EX-32.2 3798
11 logo.jpg GRAPHIC 8775
  Complete submission text file 0001437749-24-034545.txt   6388039

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA dyai-20240930.xsd EX-101.SCH 47652
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dyai-20240930_cal.xml EX-101.CAL 36559
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dyai-20240930_def.xml EX-101.DEF 378821
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE dyai-20240930_lab.xml EX-101.LAB 335761
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dyai-20240930_pre.xml EX-101.PRE 402878
59 EXTRACTED XBRL INSTANCE DOCUMENT dyai20240930c_10q_htm.xml XML 1115597
Mailing Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477
Business Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477 561-743-8333
DYADIC INTERNATIONAL INC (Filer) CIK: 0001213809 (see all company filings)

EIN.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32513 | Film No.: 241448189
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)